NOTCH1 and acute lymphoblastic leukemia: In the context of T-ALL, activating mutations of NOTCH1 are seen in over half of the cases, whereas mutations in FBXW7—a ubiquitin ligase regulating NOTCH1 degradation—occur in roughly 10–15%, often resulting in sustained NOTCH1 signaling.